# The POST-ACS Study

Study · id `cardio:ct-nct05322200` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05322200](<https://clinicaltrials.gov/study/NCT05322200>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05322200

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 140 participants.

## Technical summary

Registry record NCT05322200. Randomized; triple masking; primary purpose treatment. Start 2022-08-31 (actual); primary completion 2024-04-28 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 140 participants (planned count; ClinicalTrials.gov record NCT05322200, source copy `cardio:ctgov-nct05322200-2022-10-27`, retrieved 2026-10-26)
- Started: 2022-08-31 (actual) (ClinicalTrials.gov record NCT05322200, source copy `cardio:ctgov-nct05322200-2022-10-27`, retrieved 2026-10-26)
- Primary completion: 2024-04-28 (anticipated) (ClinicalTrials.gov record NCT05322200, source copy `cardio:ctgov-nct05322200-2022-10-27`, retrieved 2026-10-26)
- Completion: 2024-08-01 (anticipated) (ClinicalTrials.gov record NCT05322200, source copy `cardio:ctgov-nct05322200-2022-10-27`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT05322200, source copy `cardio:ctgov-nct05322200-2022-10-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05322200-2022-10-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: The POST-ACS Study
- Condition: Diabetes Mellitus
- Condition: Acute Coronary Syndrome
- Condition: Coronary Artery Disease
- Intervention (Radiation): A computerized tomography (CT) coronary angiogram
- Intervention (Procedure): Vicorder (Skidmore medical, UK)
- Intervention (Other): Blood tests for inflammation and oxidative stress markers
- Lead sponsor: Swansea Bay University Health Board
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)

## Provenance

Content hash: 595094a2ec7bb05090f100494015ddb39bb4198fe6e4c86c6c736d7afd2b0ecd
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
